Browsing Tag
Active pharmaceutical ingredients
11 posts
Why Blue Jet Healthcare (NSE: BLUEJET) is spending Rs 1,000cr on Vizag while its stock hovers near IPO price
Blue Jet Healthcare breaks ground on Rs 1,000 crore Vizag API plant as BLUEJET stock trades near lows. What the Rs 2,300 crore expansion means for investors.
Inside the new plan to end U.S. dependence on foreign drug ingredients — will it work this time?
Trump orders immediate filling of U.S. strategic API reserve with domestic production focus. See how this plan aims to secure critical medicine supply.
Supriya Lifescience boosts API capacity with Rs 125cr Module E facility
Supriya Lifescience Ltd, a leading player in the pharmaceutical industry growth segment, has unveiled its latest Module E…
Supriya Lifescience, Plasma Nutrition to partner on ioProtein manufacturing in India
Mumbai-based company Supriya Lifescience Ltd, specializing in active pharmaceutical ingredients (API), has announced a groundbreaking collaboration with United…
Ami Organics wins multi-million Euro supply contract from Fermion
Ami Organics has signed a multi-year, multi-tonne agreement with Fermion, a wholly-owned subsidiary of Finland-based Orion Corporation for…
PI Industries scraps Rs 15.3bn acquisition of lnd Swift’s API unit
PI Industries Ltd (PIIND), an Indian agri-sciences company, said that its previously announced INR 1,530 crores acquisition of…
Ind-Swift Laboratories to sell Dubai subsidiary Ind-Swift Middle East to Soft Air General Trading for $1.98m
Ind-Swift Laboratories to sell Dubai-based Ind-Swift Middle East FZ-LLC to Soft Air General Trading for $1.98M. Learn key deal details and market context.
PI Industries to acquire API business of lnd Swift Laboratories
PI Industries Ltd, an Indian agri-sciences company, has agreed to acquire the API business division of lnd Swift…
Mangalam Drugs and Organics commissions intermediate manufacturing facility
Mangalam Drugs and Organics Limited, an Indian manufacturer of active pharmaceutical ingredients (APIs), has commissioned a new intermediate…
Novartis’ Sandoz to acquire Aspen’s Japanese pharma business
Sandoz, the generic drug business of Novartis has agreed to acquire the Japanese business of Aspen Global Incorporated…